!Front Page Layout

Big changes often sneak into healthcare quietly, but this one arrives with real impact. Starting July 1, Medicare introduces a GLP-1 bridge approach that reshapes how certain prescription therapies get handled under coverage rules. These medications, often discussed in relation to diabetes care and weight management, sit at the center of growing demand and evolving policy decisions. The Centers for Medicare & Medicaid Services (CMS)